David Rendall - 01 Aug 2023 Form 4 Insider Report for PURE BIOSCIENCE, INC. (PURE)

Role
Director
Signature
/s/ David Rendall
Issuer symbol
PURE
Transactions as of
01 Aug 2023
Net transactions value
$0
Form type
4
Filing time
03 Aug 2023, 16:23:02 UTC
Previous filing
04 Oct 2022
Next filing
22 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PURE Stock Option (Right to Buy) Award $0 +125,000 $0.000000 125,000 01 Aug 2023 Common Stock 125,000 $0.1200 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2024 or January 15, 2024 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2025 or January 15, 2025.